drugset / Trial / NCT05607979
Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds
RandomizedParallel-groupTriple-blindTreatment
Summary
This is an IRB-approved multicenter study.This non-inferiority study aims to evaluate differential healing rates between Lavior Diabetic Wound Gel and other Hydrogels. Study therapy will be started in the outpatient setting and followed accordingly.
Timeline
- Start
- 2022-12-15
- Primary completion
- 2024-05-01
- Completion
- 2024-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lavior Diabetic Wound Gel | Unknown | — | Topical |
| Comparator | Smith & Nephew Solosite Gel Hydrogel Wound Dressing | Unknown | — | Topical |